• Return to HOME


  • Home
  • Services
    • Clinical & Medical Consulting
    • Business Development
    • Pharmaceutical
    • Regulatory Affairs
    • Legal Consulting
  • Our Team
    • Michael Epstein, MD, FACG, AGAF
  • News
  • Blog
  • Contact


Contact






    Key Services

    • Clinical & Medical Consulting
    • Business Development
    • Pharmaceutical
    • Regulatory Affairs
    • Legal Consulting

    News & Announcements

    Achieving successful bowel preparation with evening/morning split-dosing regimens of NER1006 versus trisulfate: post hoc analysis of a Phase 3 trial
    Jul 25, 2017
    Novel 1L Polyethylene Glycol (PEG)-Based Bowel Preparation NER1006 Achieves High Quality Bowel Cleansing with a Lower Volume than Standard 2L PEG + Ascorbate and Under 3L Total Fluid Volume Intake
    Jul 25, 2017
    Bowel preparation quality of NER1006 versus oral trisulfate solution as assessed by colonoscopists at site: a post hoc analysis from a randomized controlled trial
    Jul 25, 2017

    410-224-4887 x453

    Epstein Associates, LLC
    621 Ridgely Avenue, Suite 204
    Annapolis, MD 21401

    • Home
    • Services
    • Our Team
    • News
    • Blog
    • Contact

    © Copyright 2015, Epstein Associates, LLC
    Website Design by Calvert Design Group, Inc.